Influence of Fetomaternal Microchimerism on Maternal NK Cell Reactivity against the Child's Leukemic Blasts.

HLA KIR NK cell alloreactivity fetal microchimerism haploidentical stem cell transplantation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
04 Mar 2022
Historique:
received: 04 02 2022
revised: 28 02 2022
accepted: 02 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Persistence of fetal cells in the circulation of the mother (fetal microchimerism, FM) is associated with increased survival and reduced relapse of children with leukemia receiving a haploidentical hematopoietic stem cell transplantation (hHSCT). NK cells play an important role in maternal tolerance towards the unborn child. In this study, 70 mother-child pairs were prospectively analyzed for the occurrence of FM, KIR genotype and HLA-C type. We found that occurrence and level of FM were influenced by three maternal genetic factors: presence of an HLA-C1 allele, absence of KIR2DL3 and presence of a cen-B/B motif. Furthermore, an HLA-C match between mother and child favored persistence of FM. NK cells from FM

Identifiants

pubmed: 35327405
pii: biomedicines10030603
doi: 10.3390/biomedicines10030603
pmc: PMC8945103
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Else Kröner-Fresenius-Stiftung
ID : 2015_A35
Organisme : Fördergemeinschaft Kinderkrebs-Zentrum Hamburg
ID : Scholarship L.-M. Martin

Références

Hum Reprod. 2008 Apr;23(4):972-6
pubmed: 18263639
Eur J Immunol. 1997 Apr;27(4):979-83
pubmed: 9130653
Ann N Y Acad Sci. 2004 Jun;1022:113-8
pubmed: 15251948
J Exp Med. 2004 Oct 18;200(8):957-65
pubmed: 15477349
Nature. 1979 Jan 18;277(5693):221-3
pubmed: 95205
Hum Immunol. 2012 Jan;73(1):80-92
pubmed: 22074999
PLoS One. 2010 Dec 29;5(12):e15115
pubmed: 21206914
J Immunol Methods. 1998 Sep 1;218(1-2):155-60
pubmed: 9819132
Blood. 2008 Oct 1;112(7):2990-5
pubmed: 18492955
Biol Blood Marrow Transplant. 2014 Jan;20(1):98-105
pubmed: 24516895
Exp Hematol. 2015 Jun;43(6):462-8.e1
pubmed: 25795523
Nat Rev Immunol. 2002 Sep;2(9):656-63
pubmed: 12209134
Bone Marrow Transplant. 2021 Aug;56(8):1900-1907
pubmed: 33767404
Blood. 2011 Dec 1;118(23):6006-17
pubmed: 21921045
Immunol Today. 1990 Jul;11(7):237-44
pubmed: 2201309
Mucosal Immunol. 2022 Jan;15(1):120-129
pubmed: 34552206
Immun Inflamm Dis. 2017 Dec;5(4):461-468
pubmed: 28685972
J Clin Invest. 2007 May;117(5):1399-411
pubmed: 17446933
Annu Rev Immunol. 2001;19:291-330
pubmed: 11244039
Blood Cells Mol Dis. 2008 Jan-Feb;40(1):84-90
pubmed: 17964828
Blood. 2010 Oct 7;116(14):2411-9
pubmed: 20581313
Clin Chem. 2000 Sep;46(9):1301-9
pubmed: 10973858
Front Immunol. 2019 May 28;10:1179
pubmed: 31231370
Am J Epidemiol. 2000 Jan 1;151(1):57-62
pubmed: 10625174
Hum Reprod. 2008 Nov;23(11):2535-48
pubmed: 18658158
Blood. 2009 Jan 15;113(3):726-32
pubmed: 18945962
Bone Marrow Transplant. 2019 Aug;54(Suppl 2):743-748
pubmed: 31431703
Science. 2002 Mar 15;295(5562):2097-100
pubmed: 11896281
Nature. 1986 Feb 20-26;319(6055):675-8
pubmed: 3951539
Int J Cancer. 1975 Aug 15;16(2):216-29
pubmed: 50294
Blood. 1999 Jul 1;94(1):333-9
pubmed: 10381530
J Immunol. 2016 Dec 1;197(11):4292-4300
pubmed: 27815424
Blood. 2014 Aug 7;124(6):843-50
pubmed: 24916508
Blood. 2014 Oct 23;124(17):2744-7
pubmed: 25115891
Reprod Biomed Online. 2016 Dec;33(6):763-769
pubmed: 27751789
J Immunol. 2014 Jun 1;192(11):4949-56
pubmed: 24837152
Immunity. 1997 Dec;7(6):753-63
pubmed: 9430221
J Immunol. 2014 Jun 1;192(11):5069-73
pubmed: 24778445
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):845-50
pubmed: 25561558
Nature. 2012 Oct 4;490(7418):102-6
pubmed: 23023128
Br J Haematol. 2006 Jul;134(2):196-201
pubmed: 16846478
Immunogenetics. 2002 Jul;54(4):221-9
pubmed: 12136333
J Clin Invest. 2010 Nov;120(11):4102-10
pubmed: 20972337
J Hematother Stem Cell Res. 2001 Jun;10(3):419-25
pubmed: 11454317
Bone Marrow Transplant. 2015 Oct;50(10):1367-70
pubmed: 26098953
Transplant Cell Ther. 2022 Jan 10;:
pubmed: 35017118
Cell Mol Immunol. 2017 Apr;14(4):321-330
pubmed: 27264685
Nat Med. 2006 Sep;12(9):1065-74
pubmed: 16892062
Blood. 2002 Jun 15;99(12):4618-25
pubmed: 12036896
Nat Rev Immunol. 2013 Feb;13(2):133-44
pubmed: 23334245
Gene. 2004 Jun 23;335:121-31
pubmed: 15194195
Bone Marrow Transplant. 2019 Nov;54(11):1847-1858
pubmed: 31089287
Curr Opin Hematol. 2012 Jul;19(4):324-35
pubmed: 22517587
Tissue Antigens. 2009 Feb;73(2):188-91
pubmed: 19140829
Eur J Immunol. 1975 Feb;5(2):112-7
pubmed: 1234049
Cancers (Basel). 2020 Aug 05;12(8):
pubmed: 32764469
Clin Exp Immunol. 2004 May;136(2):373-8
pubmed: 15086404

Auteurs

Lena-Marie Martin (LM)

Research Institute Children's Cancer Center Hamburg, 20246 Hamburg, Germany.
Division of Pediatric Stem Cell Transplantation and Immunology, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

Anne Kruchen (A)

Division of Pediatric Stem Cell Transplantation and Immunology, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

Boris Fehse (B)

Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Ingo Müller (I)

Research Institute Children's Cancer Center Hamburg, 20246 Hamburg, Germany.
Division of Pediatric Stem Cell Transplantation and Immunology, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

Classifications MeSH